CERo Therapeutics (CEROW) Competitors $0.01 0.00 (-23.03%) As of 03:45 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock CEROW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CINGW, CLNNW, and COEPWShould you be buying CERo Therapeutics stock or one of its competitors? The main competitors of CERo Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. CERo Therapeutics vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity Cingulate Clene Coeptis Therapeutics CERo Therapeutics (NASDAQ:CEROW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations. Does the media favor CEROW or ATNFW? In the previous week, CERo Therapeutics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for CERo Therapeutics and 0 mentions for 180 Life Sciences. CERo Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment CERo Therapeutics Neutral 180 Life Sciences Neutral Is CEROW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets CERo TherapeuticsN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has preferable earnings and valuation, CEROW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCERo TherapeuticsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryCERo Therapeutics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CEROW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CEROW vs. The Competition Export to ExcelMetricCERo TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$240.52M$5.83B$10.07BDividend YieldN/A3.78%5.25%4.53%P/E RatioN/A42.6975.5726.01Price / SalesN/A5,025.20536.77117.75Price / CashN/A13.1937.4259.95Price / BookN/A91.6811.536.20Net IncomeN/A-$90.99M$3.29B$270.65M7 Day PerformanceN/A2.62%0.44%2.77%1 Month PerformanceN/A20.12%10.84%8.83%1 Year PerformanceN/A531.72%61.62%27.49% CERo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CEROWCERo TherapeuticsN/A$0.01-23.0%N/A+78.0%$0.00N/A0.008Short Interest ↓Gap DownATNFW180 Life SciencesN/A$0.22+8.3%N/A+1,758.8%$0.00N/A0.007Gap UpSXTPW60 Degrees PharmaceuticalsN/A$0.07-28.3%N/A+80.2%$0.00$641.41K0.002News CoverageDRTSWAlpha Tau MedicalN/A$0.29+0.9%N/A+61.6%$0.00N/A0.0080Positive NewsGap DownAPLMWApollomicsN/A$0.01+29.9%N/A+77.0%$0.00N/A0.0059Gap UpHigh Trading VolumeBCTXWBriaCell TherapeuticsN/A$0.02-16.8%N/A-87.5%$0.00N/A0.008CDIOWCardio DiagnosticsN/A$0.02-1.1%N/A-42.9%$0.00$19.51K0.007Positive NewsCELUWCelularityN/A$0.04-31.7%N/AN/A$0.00$44.59M0.00220Gap DownHigh Trading VolumeCINGWCingulateN/A$0.06flatN/A+54.0%$0.00N/A0.0020Gap UpCLNNWCleneN/A$0.03-13.7%N/A-45.3%$0.00$286K0.00100Gap DownCOEPWCoeptis TherapeuticsN/A$0.02+0.5%N/A+18.4%$0.00$263.56K0.004 Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors APLMW Competitors BCTXW Competitors CDIOW Competitors CELUW Competitors CINGW Competitors CLNNW Competitors COEPW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CEROW) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CERo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CEROW Stock Alerts